Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Whole Body DWI to FDG PET

NCT: NCT06630845 · ACTIVE_NOT_RECRUITING

NCT IDNCT06630845
StatusACTIVE_NOT_RECRUITING
Start Date2025-02-06
Completion2029-04-30
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

This is a single arm prospective trial that evaluates whole body diffusion weight imaging (DWI) compared to 18F-fludeoxyglucose (FDG) Positron Emission Tomography with Magnetic resonance imaging (PET/MRI) in participants with known metastatic cancer.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑